Terms: = Liver cancer AND PCSK7, Q16549, 9159, ENSG00000160613, PC8, SPC7, PC7, LPC
76 results:
1. Alterations in serum metabolic profiles of early-stage hepatocellular carcinoma patients after radiofrequency ablation therapy.
Zhang F; Wu J; Zhang L; Zhang J; Yang R
J Pharm Biomed Anal; 2024 Jun; 243():116073. PubMed ID: 38484637
[TBL] [Abstract] [Full Text] [Related]
2. Distinctly altered lipid components in hepatocellular carcinoma relate to impaired T cell-dependent antitumor immunity.
Cheng X; Wang W; Zhang Z; Zhang H; Zhu P; He R; Wu M; Zhou T; Jiang Y; Jiang L; Chen Y; Liang Z; Wu X; Weng X
Hepatol Int; 2024 Apr; 18(2):582-594. PubMed ID: 37823937
[TBL] [Abstract] [Full Text] [Related]
3. To be or not to be: The double-edged sword roles of liver progenitor cells.
Yan ZJ; Chen L; Wang HY
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188870. PubMed ID: 36842766
[TBL] [Abstract] [Full Text] [Related]
4. Effect of type 2 diabetes on liver images of GD-EOB-DTPA-enhanced MRI during the hepatobiliary phase.
Zhang WY; Sun HY; Zhang WL; Feng R
Sci Rep; 2023 Jan; 13(1):543. PubMed ID: 36631556
[TBL] [Abstract] [Full Text] [Related]
5. Downregulation of TUSC3 promotes EMT and hepatocellular carcinoma progression through LIPC/AKT axis.
Deng R; Lu X; Hong C; Cai R; Wang P; Xiong L; Wang X; Chen Q; Lin J
J Transl Med; 2022 Oct; 20(1):485. PubMed ID: 36274132
[TBL] [Abstract] [Full Text] [Related]
6. Quantitative parameters obtained from gadobenate dimeglumine-enhanced MRI at the hepatobiliary phase can predict post-hepatectomy liver failure and overall survival in patients with hepatocellular carcinoma.
Cai S; Lin X; Sun Y; Lin Z; Wang X; Lin N; Zhao X
Eur J Radiol; 2022 Sep; 154():110449. PubMed ID: 35901599
[TBL] [Abstract] [Full Text] [Related]
7. Effect of the learning curve on survival after laparoscopic liver resection for colorectal metastases.
Shanti H; Raman R; Chakravartty S; Belgaumkar AP; Patel AG
BJS Open; 2022 Mar; 6(2):. PubMed ID: 35380619
[TBL] [Abstract] [Full Text] [Related]
8. Activation of the Notch1-c-myc-VCAM1 signalling axis initiates liver progenitor cell-driven hepatocarcinogenesis and pulmonary metastasis.
Wu WR; Shi XD; Zhang FP; Zhu K; Zhang R; Yu XH; Qin YF; He SP; Fu HW; Zhang L; Zeng H; Zhu MS; Xu LB; Wong PP; Liu C
Oncogene; 2022 Apr; 41(16):2340-2356. PubMed ID: 35256782
[TBL] [Abstract] [Full Text] [Related]
9. Identification of a liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
Li X; Lin J; Pan Y; Cui P; Xia J
Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
[No Abstract] [Full Text] [Related]
10. Significant metabolic alterations in patients with hepatitis B virus replication observed via serum untargeted metabolomics shed new light on hepatitis B virus infection.
Yu L; Zeng Z; Tan H; Feng Q; Zhou Q; Hu J; Li Y; Wang J; Yang W; Feng J; Xu B
J Drug Target; 2022 Apr; 30(4):442-449. PubMed ID: 34844491
[TBL] [Abstract] [Full Text] [Related]
11. Assessment of the cut-off value of quantitative liver-portal vein contrast ratio in the hepatobiliary phase of liver MRI.
Takatsu Y; Nakamura M; Shiozaki T; Narukami S; Yoshimaru D; Miyati T; Kobayashi S
Clin Radiol; 2021 Jul; 76(7):551.e17-551.e24. PubMed ID: 33902888
[TBL] [Abstract] [Full Text] [Related]
12. Epithelia-Sensory Neuron Cross Talk Underlies Cholestatic Itch Induced by Lysophosphatidylcholine.
Chen Y; Wang ZL; Yeo M; Zhang QJ; López-Romero AE; Ding HP; Zhang X; Zeng Q; Morales-Lázaro SL; Moore C; Jin YA; Yang HH; Morstein J; Bortsov A; Krawczyk M; Lammert F; Abdelmalek M; Diehl AM; Milkiewicz P; Kremer AE; Zhang JY; Nackley A; Reeves TE; Ko MC; Ji RR; Rosenbaum T; Liedtke W
Gastroenterology; 2021 Jul; 161(1):301-317.e16. PubMed ID: 33819485
[TBL] [Abstract] [Full Text] [Related]
13. In pursuit of a selective hepatocellular carcinoma therapeutic agent: Novel thalidomide derivatives with antiproliferative, antimigratory and STAT3 inhibitory properties.
Nutt MJ; Yee YS; Buyan A; Andrewartha N; Corry B; Yeoh GCT; Stewart SG
Eur J Med Chem; 2021 May; 217():113353. PubMed ID: 33773263
[TBL] [Abstract] [Full Text] [Related]
14. The Impact of Geography in Hepatocellular Carcinoma: A Retrospective Population Based Study.
Yu IS; Liu SL; Zaborska V; Raycraft T; Gill S; Lim H; Davies JM
Curr Oncol; 2021 Jan; 28(1):396-404. PubMed ID: 33445517
[TBL] [Abstract] [Full Text] [Related]
15. A Lipidomic Signature Complements Stemness Features Acquisition in liver cancer Cells.
Rivas Serna IM; Romito I; Maugeri A; Lo Re O; Giallongo S; Mazzoccoli G; Oben JA; Li Volti G; Mazza T; Alisi A; Vinciguerra M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182805
[TBL] [Abstract] [Full Text] [Related]
16. High levels of modified ceramides are a defining feature of murine and human cancer cachexia.
Morigny P; Zuber J; Haid M; Kaltenecker D; Riols F; Lima JDC; Simoes E; Otoch JP; Schmidt SF; Herzig S; Adamski J; Seelaender M; Berriel Diaz M; Rohm M
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1459-1475. PubMed ID: 33090732
[TBL] [Abstract] [Full Text] [Related]
17. Roles of CCR2 and CCR5 for Hepatic Macrophage Polarization in Mice With liver Parenchymal Cell-Specific NEMO Deletion.
Bartneck M; Koppe C; Fech V; Warzecha KT; Kohlhepp M; Huss S; Weiskirchen R; Trautwein C; Luedde T; Tacke F
Cell Mol Gastroenterol Hepatol; 2021; 11(2):327-347. PubMed ID: 32896623
[TBL] [Abstract] [Full Text] [Related]
18. Synthesis of novel 2-pyrrolidinone and pyrrolidine derivatives and study of their inhibitory activity against autotaxin enzyme.
Gerokonstantis DT; Nikolaou A; Magkrioti C; Afantitis A; Aidinis V; Kokotos G; Moutevelis-Minakakis P
Bioorg Med Chem; 2020 Jan; 28(2):115216. PubMed ID: 31864778
[TBL] [Abstract] [Full Text] [Related]
19. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract] [Full Text] [Related]
20. RIPK1 and death receptor signaling drive biliary damage and early liver tumorigenesis in mice with chronic hepatobiliary injury.
Krishna-Subramanian S; Singer S; Armaka M; Banales JM; Holzer K; Schirmacher P; Walczak H; Kollias G; Pasparakis M; Kondylis V
Cell Death Differ; 2019 Dec; 26(12):2710-2726. PubMed ID: 30988397
[TBL] [Abstract] [Full Text] [Related]
[Next]
